Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » 5 fold (Expand Search), _ fold (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), e non (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » 5 fold (Expand Search), _ fold (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), e non (Expand Search)
-
61
Genes whose expression was decreased by 1 mM ouabain by more than 2-fold.
Published 2019“…<p>Genes whose expression was decreased by 1 mM ouabain by more than 2-fold.</p>…”
-
62
-
63
-
64
Effect of PMA on free FCoV RNA equivalent to 10<sup>8</sup> TCID<sub>50</sub>/mL.
Published 2023Subjects: -
65
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
66
-
67
-
68
List of 186 genes that were increased more than 2-fold from control to galactose and decreased more than 1.5-fold from galactose to 2ME2.
Published 2024“…The column of Galactose vs. 2ME2 shows the number of fold decrease in expression from Galactose to 2ME2.…”
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80